Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome

Tilly, Hervé;Gaulard, Philippe;Lepage, Eric;Dumontet, Charles;Brière, Josette;et.al.
(1997) Blood — Vol. 90, n° 9, p. 3727-3734 (1997)

Files

245247.pdf
  • Restricted Access
  • Adobe PDF
  • 117.7 KB

Details

Authors
  • Tilly, Hervé
    Author
  • Gaulard, Philippe
    Author
  • Lepage, Eric
    Author
  • Dumontet, Charles
    Author
  • Symann, MichelUCLouvain
    Author
  • Brière, Josette
    Author
Show more
Abstract
Anaplastic, CD30+, large-cell lymphoma is now a well-recognized pathologic entity that accounts for 2% to 8% of all lymphomas. Recent progress has been made in the understanding of certain biologic features found in anaplastic large-cell lymphoma, but information about its clinical behavior, in comparison to other large-cell lymphomas, is limited. The pathologic review of a large multicenter study of the treatment of aggressive lymphoma identified 146 cases of anaplastic large-cell lymphoma (ALCL) on the basis of morphology and CD30 expression. We compared initial presentation, immunophenotype, and clinical outcome of these cases with those of the 1,695 nonanaplastic diffuse large-cell lymphomas (non-ALCL) included in the same trial. Patients with ALCL were more likely to be male (P = .018) and were younger (P < .0001) than those with non-ALCL. B symptoms were more frequent in ALCL (P = .006). Skin (P < .0001) and lung (P < .05) involvement was also more frequent in ALCL, but frequency of bone marrow involvement was identical (P = . 5). Tumor cell phenotype was B in 56 cases (38%), T in 49 cases (34%), and null in 33 cases (22%). Response to chemotherapy (P = . 001), event-free survival (P = .006), and overall survival (P = . 0004) were better for ALCL than for non-ALCL. Multivariate analyses identified anaplastic character as an independent factor that predicted a longer survival. Tumor cell phenotype did not influence event-free survival (P = .72) or overall survival (P = .83). ALCL in adults is a clinicopathologic entity which, independent of its phenotypic characteristics, has a better outcome than other diffuse large-cell lymphomas.
Affiliations

Citations

Tilly, H., Gaulard, P., Lepage, E., Dumontet, C., Diebold, J., Plantier, I., Berger, F., Symann, M., Petrella, T., Lederlin, P., & Brière, J. (1997). Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood, 90(9), 3727-3734. https://doi.org/10.1182/blood.V90.9.3727 (Original work published 1997)